1. South Korea Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Kolmar Korea Co., Ltd.

Kolmar Korea Co., Ltd.

161890.KS
Kolmar Korea Co., Ltd.KR flagKorea Exchange
103,900.00
KRW
+1,100.00
- -
2.45TMarket Cap
Kolmar Korea Co., Ltd.
161890.KS
(Korea Exchange)

Recent

price

103,900.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
9,131.07
14,492.73
23,072.41
25,390.65
31,638.7
38,940.9
62,714.43
60,929.83
57,784.88
69,324.73
81,567.85
94,251.9
104,263.18
115,336.31
118,507.13
Revenue per Share
614
722
1,641
2,155
2,516
2,240
1,954
1,284
7,005
1,565
-961
227
3,830
5,299
6,651.23
Basic EPS, GAAP
416.07
310.9
-239.49
464.33
-356.57
-3,405.95
-987.73
3,954.33
-69.43
-2,380.85
1,458.4
-545.98
-1,918.55
4,731.8
5,561.42
Free Cash Flow per Basic Share
- -
105.05
102.33
159.97
202.03
294.72
292.42
325.86
330.03
344.97
649.03
726.09
824.01
959.41
- -
Dividend per Share
1,081.79
1,700.21
3,177.76
4,938.76
7,193.26
9,062.37
10,257.29
10,636.84
17,213.96
18,103.02
17,274.25
16,573.48
21,248.25
25,608.52
28,851.54
Book Value per Share
4,843.77
5,648.59
8,793.31
10,000.96
11,719.01
13,017.85
-15,743.91
-12,839.42
-4,160.74
10,168.08
7,330.17
6,453.02
10,904.19
17,958.65
19,259.31
Tangible Book Value per Share
19
19
20
21
21
21
22
23
23
23
23
23
24
24
24
Basic Weighted Avg Shares
177,779
282,229
461,253
535,846
667,469
821,616
1,357,865
1,378,886
1,322,081
1,586,333
1,865,732
2,155,676
2,452,064
2,722,419
2,797,370
Sales/Revenue/Turnover
7.9
6.97
10.16
11.33
11
8.15
6.63
7.24
9.2
5.31
3.94
6.36
7.91
8.81
9.24
Operating Margin (%)
2,775
4,529
6,999
9,639
11,841
19,189
42,017
60,590
61,739
58,372
75,425
93,728
91,974
104,125
106,893
Depreciation Expense
11,954
14,060
32,806
45,479
53,079
47,262
42,307
29,058
160,270
35,811
-21,981
5,192
90,074
125,079
157,003
Net Income, GAAP
9.77
14.56
23.65
22.63
25.39
21.62
33.55
57.18
34.72
34.58
124.16
26.79
10.34
20.55
20.27
Effective Tax Rate (%)
6.72
4.98
7.11
8.49
7.95
5.75
3.12
2.11
12.12
2.26
-1.18
0.24
3.67
4.59
5.61
Profit Margin (%)
35,556
72,669
65,135
70,938
67,887
153,961
37,860
-61,400
88,403
-5,697
-51,843
-385,334
-356,326
-350,428
-411,909
Working Capital
15,932
44,226
6,292
4,139
4,850
119,254
818,644
806,421
767,373
317,501
534,717
248,872
351,235
369,620
362,831
LT Debt
97,807
113,894
179,797
220,684
287,687
332,637
809,827
847,873
999,242
1,359,560
1,469,473
1,418,590
1,505,732
1,667,349
1,698,566
Total Equity
- -
8.78
15.03
18.34
17.74
11.7
4.84
2.12
3.67
2.44
-0.73
3.94
6.66
6.78
7.06
Return on Invested Capital (%)
- -
14.73
26.49
35.71
29.34
15.1
6.61
2.67
9.84
2.47
-2.24
0.81
4.18
4.55
5.4
Return on Capital (%)
- -
51.91
67.89
54.22
41.47
27.56
20.47
12.56
50.51
8.86
-5.43
1.34
20.5
22.66
26.67
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
766,301
861,878
970,179
LT Borrowings
402,737
330,441
323,181
LT Finance Leases
41,027
39,179
39,650
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
24
24
24
Market Capitalization
1,836,659
1,466,022
1,793,986

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
1,166,401
1,009,648
1,148,997
Cash, Cash Equivalents & STI
315,703
315,964
355,154
Accounts Receivable, Net
347,107
333,165
405,245
Inventories
452,476
324,797
357,414
Total Current Liabilities
1,383,466
1,360,077
1,560,906
Payables & Accruals
- -
- -
- -
ST Debt
766,301
861,878
970,179
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.95%
11.51%
10.73%
Free Cash Flow
293.29%
588.96%
-347.54%
Net Income, GAAP
172.66%
262.22%
38.86%
Sales/Revenue/Turnover
18.83%
15.58%
11.03%
Total Cash Common Dividend
23.09%
27.6%
16.86%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
574,790
660,271
626,505
590,498
2,452,064
2025
653,086
730,849
683,015
655,470
2,722,419
2026
728,036
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
272
1,476
651
- -
3,830
2025
561
1,480.17
1,347.33
- -
5,299
2026
1,913.6
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
824.01
2025
- -
- -
- -
- -
959.41
2026
- -
- -
- -
- -
- -
Similar Companies
BWX Limited (BWXXF)
Henkel AG & Co. KGaA (HELKF)
Galeo Concept S.A. (MLGAL.PA)
Takbo Group Holdings Limited (8436.HK)
Fu Burg Industrial Co., Ltd. (8929.TWO)
Reckitt Benckiser Group plc (RBGPF)
Business
Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty, health, and pharmaceutical products primarily as a leading original design manufacturer (ODM) and original equipment manufacturer (OEM) in South Korea and internationally. The company offers an extensive range of skincare cosmetics including toners, lotions, ampoules, essences, creams, mask sheets, mask packs, cleansers (oil, cream, water, and makeup removers), and lip balms; fragrance products such as perfumes; personal care items encompassing body and hair products; color cosmetics comprising makeup bases, primers, foundations, concealers, cushion foundations, and mascaras; powder base products like eye shadows, powder pacts, highlighters, blushers, shadings, loose powders, jelly powders, wet powders, multi-color formations, gradations, marble terracotas, hair cushions, essence powders, bubble salts, and eyebrow pencils; oil and emulsification base products including lipsticks, lip glosses, tints, essence pacts, stick foundations, sun sticks, skin covers, gel eyeliners, marble essence pacts, core sticks, two-tone sticks, marble sticks, serum sticks, eye sticks, balms, and concealers; health functional foods; and pharmaceutical dosage forms such as topical liquids, saline solutions, ointments, creams, gels, lotions, toothpastes, tablets, hard capsules, soft capsules, powders, granules, and pellets. It operates through specialized R&D labs including Skin Care, Make-up, Personal Care, UV Tech Innovation, Convergence Technology, Skin & Natural Products, Biome, Health Food, and Perfumery Labs, and provides the PLATIT147 health and beauty production platform along with real estate rental and plastic molded container manufacturing. Founded in 1990 as a joint venture with Japan's Nihon Kolmar and headquartered in Sejong City, South Korea, Kolmar Korea employs 1,152 people and serves domestic and global brands across cosmetics, pharmaceuticals, and health functional foods segments with operations in Asia, North America, Europe, and South America. Recent developments include the completion and full operation of its second U.S. factory in Scott Township, Pennsylvania, in 2025 to establish a tariff-free production base for K-beauty brands targeting North American, European, and South American markets; an ongoing strategic partnership with Amazon initiated in 2024 and expanded through events like the K-beauty Conference and sponsorship of Amazon Beauty in Seoul 2025 to support global expansion of Korean indie beauty brands; and securing 253 new customer contracts in 2024, predominantly with indie brands, reflecting a 48.7% year-over-year increase.